ALLR

0.78509.25%
JA

Joyce Ann O'Shaughnessy

Member of Scientific Advisory Board

Dr. Joyce Ann O'Shaughnessy, M.D., is Member of Advisory Board of Cure Media Group, LLC. Dr. O'Shaughnessy was Member of Scientific Advisory Board of Systems Oncology, LLC until 2025. Dr. O'Shaughnessy, MD, serves as Member of the Scientific Advisory Board at PreciseDx, Inc. since November 2024. She is Chair of the Breast Disease Committee for Sarah Cannon Research Institute in Dallas, TX. She is a Diplomate of the American Board of Internal Medicine with subspecialty certification in medical oncology. She serves as Member of Scientific Advisory Board of SynDevRx, Inc. She served as a Clinical Advisor at DNIB Unwind, Inc. (formerly BIND Biosciences, Inc.). Dr. O'Shaughnessy serves as a Program Director for the School of Breast Oncology, Baylor-Sammons Cancer Center, Dallas, Texas, USA. Dr. O'Shaughnessy is a Medical Oncologist specializing in breast cancer. She is Co-chair of Breast Cancer Research, Baylor Charles A Sammons Cancer Center, Texas Oncology, US Oncology. She is also associate director for clinical research, director of chemoprevention research and co-director of breast cancer research for US Oncology. Dr. O'Shaughnessy served as Special Assistant to the National Cancer Institute Director and coordinated the development of new cancer drug approval guidelines for the National Cancer Institute and the Food and Drug Administration. She also served as a Senior Investigator in the Medical Breast Cancer Section of the National Cancer Institute. Her research interests focus on the development of new treatments for pre-cancerous conditions of the breast. Dr. O'Shaughnessy is a Associate Editor of Clinical Breast Cancer and serves on the editorial board of Clinical Cancer Research as well as the Journal of Supportive Cancer Care. She serves as Director of United States Chinese Anti-Cancer Association, Inc. She served as Member of Oncology Advisory Board at Tioma Therapeutics, Inc. She served as a Member of OncoAssist Advisory Board at MedTrust Online, LLC and Molecular Health GmbH. She serves as a Member of US Oncology’s Scientific Advisory Board. She served as a Member of the Breast Cancer Advisory Board at Molecular Profiling Institute, Inc. (also known as Caris MPI, Inc). She is a nationally recognized expert on breast cancer prevention and treatment. Dr. O'Shaughnessy received her M.D. and Bachelor's Degree in Medical Science from Yale University Medical School and completed her internship and residency in internal medicine at Massachusetts General Hospital followed by her fellowship in medical oncology at the National Cancer Institute. She is a Member of Scientific Advisory Board at Allarity Therapeutics A/S (formerly known as Oncology Venture A/S).

Positions